3/7/2013

Roche Holding has received FDA approval for the Cobas AmpliPrep/Cobas TaqMan HCV Test, v2.0, a PCR-based assay for managing patients with the hepatitis C virus. The test measures six genotypes of HCV RNA to assess the effect of antiviral treatment.

Related Summaries